Merck (MRK) Other Non-Current Liabilities (2009 - 2026)
Merck (MRK) reported Other Non-Current Liabilities of $7.57 billion for Q2 2026, up 7.7% from $7.03 billion a year earlier but down 0.9% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Merck posted Other Non-Current Liabilities of $7.69 billion, up 18.9% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of 55.7% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $6.47 billion in FY2024, $354 million in FY2023 (-95.7%), $8.32 billion in FY2022 (+971.2%) and $777 million in FY2021 (-7.6%).
- Five-year quarterly Other Non-Current Liabilities spans a low of $208 million in Q3 2024 and a high of $9.74 billion in Q1 2022.
- Year over year, Other Non-Current Liabilities has now increased in each of the last three quarters, with an average decline of 13.9% over the last four quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q4 2022 (growth of 971.2%); the low point was Q3 2024 (a decline of 97.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.64 billion (Q1 2026), $7.69 billion (Q4 2025) and $7.66 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.57 Bn |
| Mar 31, 2026 | 7.64 Bn |
| Dec 31, 2025 | 7.69 Bn |
| Sep 30, 2025 | 7.66 Bn |
| Jun 30, 2025 | 7.03 Bn |
| Mar 31, 2025 | 6.66 Bn |
| Dec 31, 2024 | 6.47 Bn |
| Sep 30, 2024 | 208.00 Mn |
| Jun 30, 2024 | 225.00 Mn |
| Mar 31, 2024 | 226.00 Mn |
| Dec 31, 2023 | 354.00 Mn |
| Sep 30, 2023 | 7.34 Bn |
| Jun 30, 2023 | 349.00 Mn |
| Mar 31, 2023 | 353.00 Mn |
| Dec 31, 2022 | 8.32 Bn |
| Sep 30, 2022 | 499.00 Mn |
| Jun 30, 2022 | 542.00 Mn |
| Mar 31, 2022 | 9.74 Bn |
| Dec 31, 2021 | 777.00 Mn |
| Sep 30, 2021 | 902.00 Mn |
API Access
Merck Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();